Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -22.9339.0023.66644.34111.70

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -22.93 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34
Mar2020111.70

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34
476.85
Mar2020 111.7 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹172.4 Cr -9.7% -7.6% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.7%

-7.6%

-26.1%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses